tilapia
lake
viru
tilv
caus
high
mortal
rate
wild
farm
tilapia
diseas
caus
tilv
first
report
israel
viru
first
character
sinc
tilv
infect
report
differ
countri
around
world
icosahedr
viru
made
trilaminar
capsid
diamet
nm
morpholog
similar
orthomyxovirus
genom
made
ssrna
consist
segment
segment
weak
homolog
influenza
viru
c
subunit
amino
acid
ident
segment
coverag
addit
four
motif
conserv
rnadepend
rna
rnadepend
dna
polymeras
homolog
influenza
b
c
virus
tilv
initi
propos
orthomyxolik
viru
belong
genu
tilapineviru
base
ultrastructur
chemic
weak
sequenc
similar
orthomyxovirus
recent
classifi
genu
famili
amnoonvirida
order
articulaviral
transmit
horizont
infect
suscept
fish
although
vertic
transmiss
also
report
clinic
sign
includ
lethargi
exophthalmia
haemorrhag
irregular
swim
skin
eros
mortal
rang
tilvinfect
tilapia
mortal
caus
tilv
report
variou
countri
egypt
thailand
peru
malaysia
india
ecuador
current
control
measur
mostli
focus
implement
biosecur
measur
influenza
b
virus
contain
envelopeassoci
protein
name
hemagglutinin
ha
neuraminidas
na
insert
lipid
bilay
protrud
outer
surfac
spike
play
vital
role
viru
entri
bind
sialic
acid
sia
epitheli
cell
surfac
promot
fusion
envelop
cell
membran
hand
na
cleav
sialic
acid
virion
protein
prevent
clump
facilit
viru
releas
infect
cell
viral
infect
bud
ha
activ
precursor
cleav
membranebound
host
trypsinlik
proteas
kda
kda
subunit
subunit
influenza
c
virus
contain
shallow
pocket
conserv
amino
acid
distal
tip
receptorbind
site
bind
sia
receptor
either
linkag
subunit
contain
hydrophob
peptid
requir
membran
fusion
sialic
acid
sia
among
class
monosaccharid
contain
ninecarbon
backbon
normal
attach
glycan
anim
cell
gener
red
blood
cell
rbc
differ
host
speci
possess
linkag
virus
contain
bind
exampl
influenza
virus
agglutin
avian
mammalian
piscin
rbc
infecti
salmon
anemia
viru
isav
agglutin
rbc
coldwateradapt
piscin
speci
term
hemagglutinin
coin
due
bind
abil
aggreg
hemagglutin
rbc
viru
viral
properti
led
use
ha
assay
first
introduc
hirst
earli
method
identifi
quantifi
virus
agglutin
rbc
ha
assay
base
principl
hemagglutin
ha
bind
sia
receptor
rbc
form
lattic
keep
rbc
suspens
appear
diffus
suspens
abil
tilv
agglutin
rbc
tilapia
host
speci
determin
despit
identifi
similar
orthomyxovirus
follow
ha
bind
sia
receptor
viru
intern
host
cell
mostli
depend
endocyt
pathway
lead
viru
local
endosom
vesicl
uncoat
facilit
fusion
viral
envelop
endosom
membran
lead
viral
cargo
deliveri
cytoplasm
fusion
viral
envelop
endosom
membran
highli
depend
low
endosom
ph
inhibit
endosom
acidif
use
weak
basic
lysosomotrop
agent
ammonium
chlorid
chloroquin
diffus
across
lysosom
membran
due
proton
shown
interfer
orthomyxoviru
replic
henc
present
studi
want
determin
whether
replic
tilv
could
inhibit
endosom
membran
fusion
inhibitor
given
tilv
shown
properti
similar
influenza
virus
also
want
determin
whether
tilv
agglutin
piscin
avian
rbc
seen
influenza
virus
isav
found
tilv
agglutin
rbc
speci
includ
present
studi
therebi
suggest
absenc
surfac
protein
hemagglutin
properti
point
toward
receptor
sialic
acid
type
uptak
resist
toward
lysosomotrop
agent
indic
viral
uptak
mechan
independ
acidif
cell
ecacc
european
collect
authent
cell
cultur
salisburi
uk
cell
ecacc
salisburi
uk
cultiv
leibovitz
medium
glutamax
gibco
gaithersburg
md
usa
supplement
vv
fetal
bovin
serum
fb
sigmaaldrich
st
loui
mo
usa
respect
format
near
confluent
monolay
cell
use
propag
tilv
cell
use
grow
isav
near
confluent
monolay
wash
twice
phosphatebuff
salin
pb
follow
ad
viru
suspens
incub
h
tilv
isav
allow
viru
adsorpt
onto
cell
cell
cultur
flask
gentli
tilt
ensur
uniform
distribut
viru
solut
cell
monolay
h
viru
adsorpt
unbound
viru
wash
three
time
use
pb
freshli
prepar
growth
media
contain
fb
ad
cell
cell
cultur
flask
infect
tilv
cultur
isavinfect
flask
cultur
viru
harvest
cytopath
effect
cpe
fulli
develop
centrifug
supernat
flask
rpm
min
viru
supernat
harvest
flask
filter
size
remov
cell
debri
viru
store
use
influenza
viru
strain
apuerto
design
studi
grown
allantoi
membran
embryon
chicken
egg
harvest
day
viru
kindli
provid
professor
espen
rimstad
norwegian
univers
life
scienc
nmbu
norway
quantif
tilv
isav
done
cell
cultur
plate
respect
use
tissu
cultur
infect
dose
method
titer
influenza
viru
strain
apuerto
determin
use
ha
assay
chicken
red
blood
cell
verif
viru
speci
use
ha
assay
carri
use
total
rna
extract
cell
cultur
supernat
tilv
isav
wherea
allantoi
fluid
use
extract
total
rna
influenza
viru
use
modif
trizol
gibco
life
technolog
gaithersburg
md
usa
rnaeasi
mini
kit
qiagen
hilden
germani
previous
describ
cdna
synthesi
carri
reaction
volum
use
qiagen
revers
transcript
kit
involv
integr
step
remov
contamin
genom
dna
qiagen
previous
describ
studi
tilv
isav
nucleic
acid
amplifi
use
primer
specif
viru
shown
tabl
target
segment
tilv
segment
segment
isav
pcr
reaction
carri
use
qiagen
kit
accord
manufactur
guidelin
rnasefre
water
use
neg
control
red
blood
cell
rbc
use
ha
assay
collect
turkey
meleagri
gallopavo
nile
tilapia
oreochromi
niloticu
atlant
salmon
salmo
salar
l
whole
blood
nile
tilapia
atlant
salmon
cultur
norwegian
univers
life
scienc
aquarium
collect
caudal
vein
fish
immedi
mix
equal
volum
alsev
solut
sigmaaldrich
fish
use
blood
collect
anesthet
use
benzocain
mgl
blood
turkey
obtain
naiser
compani
oslo
norway
provid
commerci
basi
blood
turkey
collect
immedi
mix
equal
volum
alsev
solut
thereaft
whole
blood
alsev
solut
turkey
tilapia
salmon
wash
pb
remov
plasma
therebi
leav
rbc
ha
assay
wash
ml
rbc
dilut
ml
pb
room
temperatur
follow
centrifug
rpm
min
supernat
discard
wash
pb
repeat
three
time
pellet
contain
rbc
estim
use
graduat
mark
tube
final
wash
centrifug
follow
dilut
rbc
pb
prepar
stock
solut
final
rbc
work
solut
ha
test
prepar
dilut
rbc
suspens
pb
ratio
give
final
suspens
rbc
stock
solut
rbc
work
solut
prepar
everi
day
rbc
stock
solut
use
maximum
three
day
virus
use
ha
assay
tilv
four
concentr
isav
ha
assay
perform
vshape
plate
thermofish
scientif
waltham
usa
previous
describ
briefli
pb
ad
well
thereaft
viru
ad
first
column
give
total
mix
transfer
well
next
column
twofold
serial
dilut
mix
transfer
next
column
continu
last
column
plate
mix
last
column
discard
thereaft
rbc
ad
well
follow
gentl
mix
plate
monitor
hemagglutin
room
temperatur
min
well
show
uniform
reddish
color
rbc
suspens
regard
posit
ha
assay
well
red
dot
center
bottom
vshape
well
one
hour
incub
room
temperatur
regard
neg
measur
nonagglutin
neg
result
strip
unbound
rbc
settl
bottom
well
perform
tilt
plate
angl
highest
dilut
show
uniform
reddish
color
rbc
regard
ha
titer
viru
test
cell
seed
cultureflask
growth
media
follow
incub
confluenc
confluent
monolay
wash
twice
use
pb
treatment
use
variou
concentr
experi
use
treatment
cell
done
two
part
first
part
determin
toxic
differ
concentr
cell
concentr
test
mm
differ
concentr
mix
growth
media
put
cell
follow
incub
cell
observ
everi
hour
check
toxic
base
morpholog
chang
cell
death
second
part
test
impact
replic
tilv
cell
optim
durat
caus
toxic
cell
determin
cell
treat
viru
adsorpt
postadsorpt
treatment
done
h
postinfect
hpi
cell
infect
tilv
multipl
infect
moi
adsorb
h
allow
viru
bind
onto
cell
cell
cultur
flask
gentli
tilt
ensur
uniform
distribut
viru
solut
cell
monolay
h
viru
adsorpt
unbound
viru
wash
three
time
use
pb
cell
cultur
normal
growth
media
contain
fb
treatment
three
neg
control
cell
cultur
flask
without
treatment
cell
treat
without
viru
infect
includ
studi
posit
control
group
consist
cell
infect
viru
moi
without
treatment
cell
incub
monitor
daili
cytopath
effect
cpe
develop
cpe
observ
total
rna
extract
viru
quantif
treatment
group
use
modif
trizol
gibco
life
technolog
rnaeasi
mini
kit
qiagen
method
previous
describ
quantit
real
time
pcr
qrtpcr
perform
triplic
uninfect
infect
cell
use
primer
target
tilv
segment
tabl
speciesspecif
primer
use
detect
differ
virus
use
hemagglutin
assay
pcr
follow
gel
electrophoresi
amplifi
product
specif
virus
figur
detect
bp
band
tilv
lane
tilv
bp
band
lane
bp
band
isav
lane
isav
shown
figur
concord
expect
amplicon
product
viru
shown
tabl
note
band
detect
rnase
free
water
nc
lane
test
tilv
isav
primer
therebi
indic
unspecif
bind
primer
use
gel
electrophoresi
analysi
red
blood
cell
turkey
use
repres
avian
speci
ha
assay
virus
use
assay
titrat
twofold
dilut
row
start
highest
concentr
ha
unit
isav
titrat
twofold
dilut
row
b
c
start
highest
concentr
column
ha
titer
use
direct
link
tilv
isav
shown
figur
four
concentr
tilv
start
dilut
twofold
row
e
f
g
respect
row
h
use
neg
pb
control
note
highest
dilut
factor
agglutin
turkey
erythrocyt
shown
figur
weak
strip
unbound
turkey
rbc
plate
held
angl
shown
figur
elut
turkey
erythrocyt
observ
even
h
incub
room
temperatur
h
incub
howev
agglutin
turkey
erythrocyt
isav
tilv
figur
strip
rbc
shown
figur
plate
held
angl
order
detect
strip
nonagglutin
rbc
similar
observ
seen
pb
neg
control
row
h
summari
agglutin
turkey
erythrocyt
neither
piscin
virus
tilv
isav
agglutin
turkey
rbc
tabl
tilapia
atlant
salmon
rbc
use
repres
piscin
speci
ha
assay
figur
show
layout
virus
use
assay
tilv
use
start
concentr
dilut
twofold
row
b
row
c
isav
row
e
f
row
g
h
contain
pb
neg
control
figur
show
agglutin
tilapia
erythrocyt
tilv
demonstr
row
b
similar
pb
neg
control
row
g
h
row
e
f
figur
show
weak
agglutin
tilapia
rbc
isav
dilut
figur
show
strip
rbc
dilut
row
e
f
hemagglutin
plate
strip
becam
promin
dilut
onward
similar
pb
neg
control
howev
row
c
show
highest
dilut
factor
agglutin
tilapia
rbc
row
b
seen
figur
figur
show
highest
dilut
factor
isav
agglutin
atlant
salmon
erythrocyt
wherea
highest
dilut
factor
elut
atlant
salmon
agglutin
rbc
isav
observ
h
incub
room
temperatur
h
incub
row
e
f
figur
show
agglutin
atlant
salmon
erythrocyt
tilv
similar
observ
seen
row
g
h
pb
neg
control
summari
find
show
abl
agglutin
turkey
atlant
salmon
tilapia
rbc
isav
agglutin
atlant
salmon
tilapia
rbc
contrast
tilv
abl
agglutin
turkey
tilapia
atlant
salmon
rbc
tabl
treatment
cell
differ
concentr
show
leav
media
h
cell
toxic
concentr
mm
lower
concentr
ie
mm
toxic
effect
even
left
cell
end
experi
media
replac
mainten
media
plu
fb
h
treatment
toxic
effect
cell
high
concentr
mm
henc
concentr
mm
select
test
effect
tilv
replic
replac
mainten
media
treatment
choic
mm
rang
concentr
use
sever
previou
studi
therefor
pretreat
group
media
ad
min
viru
adsorpt
treatment
perform
viru
adsorpt
group
design
hpi
media
ad
hpi
later
replac
mainten
media
postinfect
group
cytopath
effect
cpe
seen
day
postinfect
dpi
includ
format
vacuol
patch
detach
cell
monolay
infect
tilv
figur
figur
show
signific
differ
mean
viral
titer
base
ctvalu
detect
qrtpcr
three
replic
tilvinfect
cell
treat
mm
hpi
addit
signific
differ
mean
viru
titer
detect
posit
control
without
treatment
group
treat
hpi
main
find
studi
tilv
agglutin
tilapia
atlant
salmon
rbc
treatment
neither
inhibit
enhanc
tilv
replic
cell
influenza
viru
strain
apuerto
agglutin
avian
piscin
rbc
isav
agglutin
atlant
salmon
tilapia
rbc
agglutin
tilapia
rbc
isav
observ
studi
weak
inabl
tilv
agglutin
rbc
speci
includ
suggest
absenc
surfac
protein
abl
agglutin
rbc
lack
observ
effect
lysosomotrop
agent
indic
acidificationindepend
uptak
mechan
although
addit
studi
carri
understand
detail
mechan
involv
observ
isav
properti
line
observ
made
falk
et
al
show
isav
agglutin
piscin
rbc
avian
rbc
similarli
shown
author
influenza
viru
agglutin
avian
piscin
rbc
corrobor
find
differ
orthomyxovirus
bind
differ
sia
receptor
host
cell
human
influenza
b
virus
subunit
bind
sia
receptor
attach
either
linkag
avian
equin
influenza
virus
bind
sia
contain
linkag
swine
influenza
virus
bind
sia
attach
linkag
erythrocyt
sever
speci
chicken
turkey
equin
guinea
pig
human
possess
linkag
henc
like
influenza
viru
strain
use
bind
linkag
rbc
found
differ
host
speci
includ
avian
piscin
speci
paramyxovirus
newcastl
diseas
viru
ndv
share
antigen
determin
orthomyxovirus
virus
use
receptor
includ
coronavirus
receptor
report
variou
speci
human
rabbit
rat
guinea
pig
hors
chicken
turkey
goos
salmonid
crucian
carp
mollusk
sea
urchin
unlik
influenza
c
isav
specif
bind
glycan
host
cell
use
hemagglutininesteras
protein
uniqu
compar
ha
hemagglutininesterasefus
hef
protein
orthomyxovirus
sequenc
ident
low
isav
sequenc
share
sequenc
similar
nonorthomyxovirus
torovirus
coronavirus
high
specif
isav
protein
glycan
make
differ
orthomyxovirus
may
account
isav
lower
tropism
mostli
bind
fish
rbc
unlik
orthomyxovirus
bind
wide
rang
rbc
differ
avian
mammalian
piscin
speci
given
ha
protein
bind
rbc
hemagglutin
assay
also
serv
ligand
bind
sia
receptor
use
viru
entri
host
cell
inabl
tilv
bind
rbc
suggest
use
mechan
differ
orthomyxovirus
entri
replic
within
host
cell
observ
support
find
regard
treatment
cell
infect
tilv
studi
cell
attach
replic
mechan
orthomyxovirus
show
ha
bind
sia
receptor
host
cell
viru
taken
endosom
compart
endocytosi
low
endosom
ph
mediat
fusion
viral
envelop
endosom
membran
facilit
viru
uncoat
lead
releas
nucleoprotein
requir
viru
replic
aciddepend
cellular
proteas
ph
depend
viral
uncoat
complet
parallel
fusion
viral
envelop
endosom
membran
rais
endosom
lysosom
ph
ad
weak
lysosomotrop
base
like
chloroquin
shown
prevent
viru
uncoat
therebi
block
viru
replic
phenomenon
support
sever
studi
includ
matlin
et
al
show
treatment
canin
kidney
mdck
cell
abl
block
uncoat
influenza
viru
endosom
compart
lead
replic
failur
culmin
prevent
infect
virus
replic
shown
inhibit
treatment
includ
alphavirus
herp
simplex
viru
type
reovirus
coronavirus
present
studi
treatment
neither
inhibit
enhanc
tilv
replic
cell
differ
viru
replic
nontreat
cell
altogeth
data
present
show
tilv
agglutin
avian
piscin
rbc
abil
replic
cell
suggest
could
use
uptak
mechan
differ
orthomyxovirus
therefor
futur
studi
seek
elucid
mechan
tilv
bind
host
cell
mode
entri
infect
cell
